Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

MLA

John, Ranjit, et al. “Improved Survival and Decreasing Incidence of Adverse Events with the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy.” The Annals of Thoracic Surgery, vol. 86, no. 4, Oct. 2008, pp. 1227–34. EBSCOhost, https://doi.org/10.1016/j.athoracsur.2008.06.030.

APA

John, R., Kamdar, F., Liao, K., Colvin-Adams, M., Boyle, A., & Joyce, L. (2008). Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. The Annals of Thoracic Surgery, 86(4), 1227–1234. https://doi.org/10.1016/j.athoracsur.2008.06.030

Chicago

John, Ranjit, Forum Kamdar, Kenneth Liao, Monica Colvin-Adams, Andrew Boyle, and Lyle Joyce. 2008. “Improved Survival and Decreasing Incidence of Adverse Events with the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy.” The Annals of Thoracic Surgery 86 (4): 1227–34. doi:10.1016/j.athoracsur.2008.06.030.